X4 Pharmaceuticals (XFOR) Shares Issued (2019 - 2025)
X4 Pharmaceuticals (XFOR) reported Shares Issued of $146.0 million for Q4 2025, up 49573.47% on a YoY basis from N/an in Q4 2024, and up 57.98% quarter-over-quarter from $92.4 million in Q3 2025.
X4 Pharmaceuticals (XFOR) Shares Issued (2019 - 2025) Analysis & Trends
X4 Pharmaceuticals has reported Shares Issued for 7 years, with the latest figure at $146.0 million in Q4 2025.
- For the quarter ending Q4 2025, Shares Issued rose 49573.47% year-over-year to $146.0 million; the trailing twelve-month figure through Dec 2025 stood at $238.6 million (up 101873.93% YoY), and the FY2025 full-year result was $238.5 million, up 81032.65% from the prior year.
- Shares Issued for Q4 2025 stood at $146.0 million, up from $92.4 million in the prior quarter.
- The five-year high for Shares Issued was $146.0 million in Q4 2025, with the low at -$159000.0 in Q3 2024.
- Historically, Shares Issued has averaged $21.7 million across 5 years, with a median of $103000.0 in 2021.
- Annual changes were most pronounced in 2024 — Shares Issued slumped 8050.0% — and 2025, when it soared 58240.88%.
- X4 Pharmaceuticals' Shares Issued stood at $103000.0 in 2021, then jumped by 33.98% to $138000.0 in 2022, then declined by 29.71% to $97000.0 in 2023, then jumped by 203.09% to $294000.0 in 2024, then jumped by 49573.47% to $146.0 million in 2025.
- The last three Shares Issued figures came in at $146.0 million (Q4 2025), $92.4 million (Q3 2025), and $294000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 5.40 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 27.00 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 26,927.15 |
| 10 | X4 Pharmaceuticals | 156.06 Mn | 156.06 Mn | 2.20 Mn | 146.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 146.04 Mn |
| Dec 31, 2025 | 146.04 Mn |
| Sep 30, 2025 | 92.44 Mn |
| Sep 30, 2025 | 92.44 Mn |
| Dec 31, 2024 | 294,000.00 |
| Dec 31, 2024 | 294,000.00 |
| Sep 30, 2024 | -159,000.00 |
| Sep 30, 2024 | -159,000.00 |
| Dec 31, 2023 | 97,000.00 |
| Dec 31, 2023 | 97,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Dec 31, 2022 | 138,000.00 |
| Dec 31, 2022 | 138,000.00 |
| Jun 30, 2022 | 70,000.00 |
| Jun 30, 2022 | 70,000.00 |
| Dec 31, 2021 | 103,000.00 |
| Dec 31, 2021 | 103,000.00 |
| Jun 30, 2021 | 116,000.00 |
| Jun 30, 2021 | 116,000.00 |